MedTrace Logo

LEAN Project: Weight Loss and Appetite Suppression

NCT00153790 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-03-13

No results posted yet for this study

Summary

The primary aim is to examine whether the intake of PhosphoLEAN is effective in aiding a cohort of women in losing weight. Participants taking the supplement will have significantly greater improvement in study outcomes than those taking the placebo.

Conditions

Interventions

DRUG

PhosphoLean

Sponsors & Collaborators

  • Chemi Nutra

    collaborator UNKNOWN

  • The Cooper Institute

    lead OTHER

Principal Investigators

  • Conrad Earnest, PhD · The Cooper Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-04-30
Completion
2006-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00153790 on ClinicalTrials.gov